Cardiac Glycosides (Digoxin) Cardiac glycosides represent a family of compounds that are derived from the foxglove plant (Digitalis purpurea). The therapeutic benefits of digitalis were first described by William Withering in 1785. Initially, digitalis was used to treat dropsy, which is an old term for edema.
The active components of the foxglove (Digitalis purpurea and Digitalis lanata) are classified as cardiac glycosides or cardiotonic steroids and include the well-known digitalis leaf, digitoxin, and digoxin; ouabain is a rapid. What are cardiac glycosides? Cardiac glycosides are a class of medications commonly derived from foxglove plants, such as Digitalis lanata and Digitalis purpurea. The most commonly prescribed cardiac glycoside is digoxin.
digitalis, drug obtained from the dried leaves of the common foxglove (Digitalis purpurea) and used in medicine to strengthen contractions of the heart muscle. Belonging to a group of drugs called cardiac glycosides, digitalis is most commonly used to restore adequate circulation in patients with congestive heart failure, particularly as caused by atherosclerosis or hypertension. The drug is.
Cardiac glycosides examples include digoxin (Cardoxin® and Lanoxin®), digitalis and digitoxin. They come from the digitalis (foxglove) plant, which is where they get their names. Other cardiac glycoside drugs include oleandrin, bufalin and ouabain.
Digoxin is the most commonly prescribed cardiac glycoside. Who needs to have cardiac glycosides? Cloning of the "Na+ pump" (Na+,K+-ATPase or NKA) and identification of a circulating ligand, endogenous ouabain (EO), a cardiotonic steroid (CTS), triggered seminal discoveries regarding EO and its NKA receptor in cardiovascular function and the pathophysiology of heart failure (HF) and hypertension.
Cardiotonic digitalis preparations were a preferred treatment for HF for two centuries. Emphasis is placed on clinical use of digitalis and the cardiac glycosides rather than on chemical or pharmacologic studies. The recent important work on the mechanism of action of digitalis in congestive heart failure is well reviewed and expertly analyzed.
Each of the commonly used glycosides. The active components of the foxglove (Digitalis purpurea and Digitalis lanata) are classified as cardiac glycosides or cardiotonic steroids and include the well-known digitalis leaf, digitoxin, and digoxin; ouabain is a rapid-acting glycoside usually obtained from Strophanthus gratus. What are cardiotonic steroids?
Digoxin belongs to the class of medicines called digitalis glycosides. It is used to improve the strength and efficiency of the heart, or to control the rate and rhythm of the heartbeat. This leads to better blood circulation and reduced swelling of the hands and ankles in patients with heart problems.
Digitalis is a primary source of potent cardiac glycosides (e.g., digoxin and digitoxin), used to treat heart failure and arrhythmias. These compounds are derived from the dried leaves of Digitalis purpurea and Digitalis lanata.